Drug ID: | NPD7229 |
Drug Name: | Fasiglifam |
Molecular Formula: | C29H32O7S |
Canonical SMILES: | OC(=O)C[C@@H]1COc2c1ccc(c2)OCc1cccc(c1)c1c(C)cc(cc1C)OCCCS(=O)(=O)C |
Standard InCHI: | InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1 |
Standard InCHIKey: | BZCALJIHZVNMGJ-HSZRJFAPSA-N |
Max Developmental Stage: | Phase 3 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002926; DIB002820 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 24857286; 57339446 |
ChEBI | |
CAS Number |
Molecular Weight | 524.19 |
ALogP | -0.2539 |
MLogP | 3.77 |
XLogP | 6.617 |
HDA | 4 |
HBD | 1 |
Rotatable Bonds | 15 |
TPSA | 107.51 |
RO5 Violation | 2 |